Home
Myriad

Myriad Market Share Analysis for August 2026

Learn about Myriad Genetics, the importance of our mission and vision and how it drives everything we do in our pursuit to advance health and well-being for all.

Health > Biotechnology and Pharmaceuticals

Domainmyriad.com

Year Founded1991

Employees1001 - 5000

Annual Revenue$500M - $1B

Myriad

Myriad (including company regionals)

myriad.com

See more website traffic and engagement information

Myriad Revenue up to August 2026 is 500M - 1B

revenue generated by Myriad top domains

Myriad top domains revenue over 3 years

Revenue for Myriad top domains

myriad.com500M - 1B

See more with Sales Intelligence

Total visits to Myriad's top domains

Understand Myriad market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

myriad.com298.8K

See more with Sales Intelligence

Avg. visit duration in Myriad's top domains

Analyze Myriad engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

myriad.com00:04:39

See more with Sales Intelligence

Avg. pageviews on Myriad's top domains

See how Myriad keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

myriad.com13.13

See more with Sales Intelligence

Myriad top competitors by domain

Top similar sites in August 2026, ranked by their affinity

ambrygen.comCompany NameAmbry GeneticsEmployees501 - 1000HQUnited States, California, Aliso ViejoAnnual revenue$200M - $500MTotal visits205.8KHealth > Health Conditions and Concerns

Top technologies used by Myriad

These are the website technologies, by industry, used by Myriad top domains

Advertising (27)

Google Adsense

Conversion & Analytics (13)

Google Analytics

Payment & Currencies (10)

Cart Functionality

Widget (10)

Twemoji

More Technologies

15

See all

News & Signals from Myriad

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMyriad Genetics, Inc. had revenue of $191M on Jul 1st '26.Myriad Genetics NASDAQ: MYGN reported second-quarter 2026 revenue of $190.7 million, down 11% from a year earlier, as a 1% decline in total test volume and a 9% decrease in revenue per test weighed on results.

NewsMyriad Genetics, Inc. had issues with weaker prenatal volumes and reimbursement pressure in hereditary cancer testing on Jul 1st '26.* Myriad lowered 2026 revenue guidance to $770 million-$790 million and gross-margin guidance to 66%-67%, citing weaker prenatal volumes and reimbursement pressure in hereditary cancer testing.